AmCham submitted comments on the Proposed Revised Guidelines for Similar Biologics to Drugs Controller General India (DCGI)

May 19, 2016 | Pharma Committee

These recommendations were submitted by AmCham Pharma Committee to Drugs Controller General India (DCGI) on 26th April 2016.